XtalPi
Assembly Line
🧪 XtalPi Announces Collaboration with Lilly, Using AI + Robotics to Uncover First-in-class Therapeutics
XtalPi Inc., a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, announced an AI drug discovery collaboration of up to $250 million in upfront and milestone payments with Eli Lilly and Company. The collaboration will leverage XtalPi’s integrated AI capabilities and robotics platform to de novo design and deliver drug candidates for an undisclosed target.